Fertiga is a spin-off company from one of the global IVF leading centers, UZ Brussels in Belgium.
UZ Brussels (and its Center of Reproductive Medicine) has been pioneering IVF, with the first ICSI baby (Intracytoplasmic Sperm Injection) worldwide being born in 1992. Fertiga is the first provider worldwide on the analysis of cumulus cells to improve live birth rates.
Our goal is to improve fertility treatments, make them accessible to more couples and reduce the overall burden of treatment. We aim to get as many women as possible pregnant from the first attempt.
Our motto is one try, one child.
Meet our founders
Prof. Dr. Johan Smitz, Chief Medical Officer
Prof Smitz – a medical doctor by training – is the head of the Follicle Biology (FOBI) group at the Free University of Brussels (VUB) and a member of the clinical diagnostics department at the University Hospital of VUB (UZ Brussels). Johan has been involved for more than 10 years in the development of new diagnostic modalities to predict oocyte competence for pregnancy outcomes in women undergoing in-vitro fertilization after hormone stimulation. This technology is a key component of Fertiga’s offering in the market.
Ir. Elien Van Hecke, Chief Commercial Officer
Ms. Van Hecke is a bioengineer by training and holds a master’s in business economics. She has seven years of experience in different marketing and sales roles both in Biotech (Innogenetics) and large diagnostic companies (Fujirebio/Roche). Elien decided to exit Roche Belgium to start up Fertiga in 2017.
Prof. Dr. André Rosenthal, Chief Executive Officer
Prof Rosenthal – a molecular biologist by training – was a member of the leadership group (2015-2017) of Roche Sequencing, a business unit headquartered in California. He was the sole founder and CEO of Signature Diagnostic, a cancer diagnostic company in Germany, which he sold to Roche in 2015. Andre has extensive experience in clinical and experimental cancer research, human genetics, and genomics. From 1994 to 2001 he was the head of the German Human Genome Sequencing Project contributing to the sequencing of chromosome 21 in 2000. He joined Fertiga at the beginning of 2018.